• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V. MEDEX CONTRAST ADMINISTRATION SETS; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V. MEDEX CONTRAST ADMINISTRATION SETS; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number MX20108
Device Problem Disconnection (1171)
Patient Problem Chemical Exposure (2570)
Event Date 02/12/2024
Event Type  Injury  
Manufacturer Narrative
D4: lot number, full udi, expiration date and h4: manufacture date are unknown; no information has been provided to date.H3: other; device not returned to manufacturer.Device evaluation: no product was returned, and analysis was conducted using customer provided photos.It was observed that the product shown on the pictures are not manufactured by icu medical as the pictures were compared with the drawing of reported part number.A device history record (dhr) review could not be performed as the lot number was unknown.Awareness was given to personnel who perform the assembly process of the reported part number.If the product is returned the manufacturer will re-open the complaint for further device analysis.
 
Event Description
It was reported that they have had multiple incidents of the needleless connectors falling out when they¿re supposed to be bonded on.The 8-port manifold was infusing mycophenylate (hazardous drug) when another manifold port with used tubing for ganciclovir (also hazardous) disconnected below needleless connector.They have been seeing and reporting the same defect.This caused a hazardous medication spill of mycophenylate ~100 ml.Inherent hazardous drug exposure risk to staff, patient, others, and infection risk from open tubing.Caused interruption of vital iv therapies waste/cost of replacement therapies and tubing.There was known patient involvement and patient harm.Product will not be returned due to hazardous drug spill.Adverse patient effects and treatment were not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDEX CONTRAST ADMINISTRATION SETS
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V.
carretera miguel alemán km21.7
apodaca nuevo leon
MX 
Manufacturer Contact
reed covert
6000 nathan lane north
minneapolis, MN 55442
2247062300
MDR Report Key18975045
MDR Text Key338550819
Report Number9616567-2024-00051
Device Sequence Number1
Product Code FPA
UDI-Device Identifier10351688509772
UDI-Public(01)10351688509772
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K790408
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Nurse
Type of Report Initial
Report Date 03/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/25/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberMX20108
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/27/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GANCICLOVIR; MYCOPHENYLATE
-
-